Se analizaron los resultados de pruebas de sensibilidad practicadas a Shigella sp. aisladas en el período 1993-1999, y se recolectaron, al azar, cepas aisladas en laboratorios de la ciudad y del hospital, a fin de verificar, en condiciones controladas, su identidad y sensibilidad a 12 antimicrobianos. De 184 cepas aisladas, 63 fueron Sh. flexneri (34,2%), Sh. boydii 62 (33,7), Sh. sonnei 28 (15,3%) y Sh. dysenteriae 20 (11%), cuya sensibilidad a más de 16 antimicrobianos probados durante el período demostró que el 80% eran resistentes a ampicilina, 68% a trimetoprim/sulfametoxazol, 57% a cloranfenicol y el 10% a imipenem y ciprofloxacina, variando, entre estos rangos, la resistencia demostrada contra los otros. De las colectadas al azar, 15 Sh. flexneri (60%), 7 Sh. boydii (25%), Sh. dysenteriae 2 (8%) y Sh. sonnei 1 (4%), 80% resistentes a tetraciclina, el 72% resistentes a ampicilina/sulbactam y trimetoprim/sulfametoxazol, 56% resistentes a cloranfenicol y a amikacina, y el 100% sensibles a ciprofloxacina y cefixime. La frecuencia de especies de Shigella aisladas en el hospital fue diferente de las colectadas al azar, y su espectro de sensibilidad sensiblemente distinto. La demostración de Shigella sp. con moderada y alta resistencia en la región es un hallazgo importante, que sugiere acentuar la vigilancia epidemiológica sobre shigelosis, las especies que prevalecen y su comportamiento ante las drogas utilizadas en el tratamiento.
The isolation of 184 strains of Shigella sp, during a 7 years period, showed that 63 (34.2%) were Sh. flexnery, 62 (33.7%) Sh. boydii, 28 (15.3%) Sh. sonnei, and 20 (11%) Sh. dysenteriae. The global susceptibility test against more than 16 different antimicrobial agents, indicated that 80% of them were resistant to ampicilin, 68% to trimethoprim/sulfamethoxazole, 57% to cloramphenicol, and 10% to imipenem and ciprofloxacin. Strains of Shigella collected at random in the area and identified under controlled laboratory condition, 15 out of 25 (60%) proved to be Sh. flexneri, 25% Sh. boydii, 8% Sh. dysenteriae and 4% Sh. sonnei being resistant to ampicillin/sulbactan, tetracycline, and to trimethoprim/sulfamethoxazole more tan 72% of them, but a 100% susceptible to ciprofloxacin and cefixime. The frequency of Shigella species isolated at the hospital and those collected in the area, were different, as well as the susceptibility profile to antimicrobial agents tested. The demonstration of strains with moderate to height resistance level, seems to be an important fact on behalf of shigellosis epidemiological surveillance effort in the area, its prevalence and susceptibility to drugs used for treatment.